02/11/2025
8:28 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
4:32 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
02/10/2025
4:35 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/30/2025
4:27 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/30/2025
4:28 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/23/2025
5:08 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/23/2025
5:11 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/17/2025
7:13 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
7:17 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/16/2025
5:51 AM | Lipella Pharmaceuticals (Filer)
| Form 424B3 | |
01/15/2025
11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for LIPO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/13/2025
7:42 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
4:25 PM | Lipella Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/07/2025
4:28 PM | Lipella Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/06/2025
4:25 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
8:22 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
8:25 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
3:11 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
8:28 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
8:31 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
12/27/2024
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:29 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:26 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
4:01 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:24 PM | Lipella Pharmaceuticals (Filer)
| Form PRE 14A | |
11/01/2024
4:00 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
4:00 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/17/2024
4:00 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/11/2024
4:10 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:05 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
08/13/2024
3:13 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:44 AM | Lipella Pharmaceuticals (Filer)
| Form ARS | |
08/12/2024
7:25 AM | Lipella Pharmaceuticals (Filer)
| Form DEF 14A | |
08/06/2024
3:50 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
4:20 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
10:50 AM | Lipella Pharmaceuticals (Filer)
| Form 424B5 | |
05/15/2024
3:39 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
03/19/2024
5:25 PM | Lipella Pharmaceuticals (Issuer)
Yoshimura Naoki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:26 PM | Lipella Pharmaceuticals (Issuer)
Pruchnic Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:15 PM | Kim Byong (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:18 PM | Cohen Daniel R (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:19 PM | Johnston Douglas (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:21 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:22 PM | Birder Lori (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:24 PM | Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
12:31 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
11:19 AM | Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:20 AM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:13 AM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/15/2024
11:15 AM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/15/2024
5:04 AM | Lipella Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2024
4:03 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/06/2024
4:05 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
